Jeremy Duffield is the founder of Prime Medicine. Prime Medicine has raised $315M in total funding. Latest round: Series A.
Jeremy Duffield is the Chief Scientific Officer and co-founder of Prime Medicine, a gene editing startup based in Cambridge, Massachusetts. He has held his current role since December 2020. The company launched with $315 million to pioneer a new type of CRISPR-based gene editing technology.
Full founder directory · Investor directory · Company funding database · Fundraising library